4BA A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC)

Michael A. Carducci, Anne Armstrong, Siew C. Ng, Robert Huddart, Neeraj Agarwal, Denis Khvorostenko, O. O. Lyulko, Arija Brize, Nicholas J. Vogelzang, R. Delva,

European Journal of Cancer · 2015 · 10 citations · 0 references

Concepts